QuVa Pharma Announces Immediate Significant Capacity Increase for Compounded Sterile Injectable Preparations

— Company more than doubles capacity at its New Jersey location through additional production, post compounding and distribution capabilities — SUGAR LAND, TX – September 26, 2019 – QuVa Pharma, Inc. today announced it is completing the next phase of capacity expansion at its Bloomsbury, New Jersey, state-of-the-art cGMP compliant 503B FDA registered manufacturing facility. […]